A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer

Autor: Jinno, H. *, Sakata, M., Hayashida, T., Takahashi, M., Mukai, M., Ikeda, T., Kitagawa, Y.
Zdroj: In Annals of Oncology June 2010 21(6):1262-1266
Databáze: ScienceDirect